{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:22:21Z","timestamp":1788355341560,"version":"build-2803163510"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12,27]]},"DOI":"10.1097\/tp.0b013e3182a64db9","type":"journal-article","created":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T09:20:04Z","timestamp":1379668804000},"page":"1082-1088","source":"Crossref","is-referenced-by-count":32,"title":["Alemtuzumab Induction in Renal Transplantation Permits Safe Steroid Avoidance with Tacrolimus Monotherapy"],"prefix":"10.1097","volume":"96","author":[{"given":"Matthew P.","family":"Welberry Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravind","family":"Cherukuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chas G.","family":"Newstead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.P.","family":"Lewington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niaz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krish","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmini","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Tibble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Giddings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210129","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1098\/rstb.2005.1702","article-title":"CAMPATH: from concept to clinic.","volume":"360","author":"Waldmann","year":"2005","journal-title":"Philos Trans R Soc B"},{"key":"R2-12-20210129","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.surg.2004.06.015","article-title":"Campath-1H in renal transplantation: the University of Wisconsin experience.","volume":"136","author":"Knechtle","year":"2004","journal-title":"Surgery"},{"key":"R3-12-20210129","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0140-6736(05)77739-4","article-title":"Prope tolerance, perioperative Campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients.","volume":"351","author":"Calne","year":"1998","journal-title":"Lancet"},{"key":"R4-12-20210129","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1111\/j.1600-6143.2005.01067.x","article-title":"Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab inductionlong-term results.","volume":"5","author":"Kaufman","year":"2005","journal-title":"Am J Transplant"},{"key":"R5-12-20210129","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jamcollsurg.2004.12.024","article-title":"Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with thymoglobulin or Campath.","volume":"200","author":"Shapiro","year":"2005","journal-title":"J Am Coll Surg"},{"key":"R6-12-20210129","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-6143.2008.02492.x","article-title":"Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up.","volume":"9","author":"Tan","year":"2009","journal-title":"Am J Transplant"},{"key":"R7-12-20210129","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.TP.0000128625.29654.EB","article-title":"The use of Campath-1H as induction therapy in renal transplantation: preliminary results.","volume":"78","author":"Ciancio","year":"2004","journal-title":"Transplantation"},{"key":"R8-12-20210129","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/TP.0b013e31822ca7ca","article-title":"Kidney transplantation with minimized maintenance: alemtuzumab induction with tacrolimus monotherapyan open label, randomized trial.","volume":"92","author":"Chan","year":"2011","journal-title":"Transplantation"},{"key":"R9-12-20210129","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1009546","article-title":"Alemtuzumab induction in renal transplantation.","volume":"364","author":"Hanaway","year":"2011","journal-title":"N Engl J Med"},{"key":"R10-12-20210129","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1111\/j.1600-6143.2004.00583.x","article-title":"Steroid sparing with tacrolimus and mycophenolate mofetil in renal transplantation.","volume":"4","author":"Borrows","year":"2004","journal-title":"Am J Transplant"},{"key":"R11-12-20210129","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(03)13175-3","article-title":"Tolerogenic immunosuppression for organ transplantation.","volume":"361","author":"Starzl","year":"2003","journal-title":"Lancet"},{"key":"R12-12-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e3181c518cc","article-title":"Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis.","volume":"89","author":"Knight","year":"2010","journal-title":"Transplantation"},{"key":"R13-12-20210129","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1600-6143.2004.00765.x","article-title":"Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients.","volume":"5","author":"Opelz","year":"2005","journal-title":"Am J Transplant"},{"key":"R15-12-20210129","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/j.1600-6143.2008.02273.x","article-title":"Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: results of a prospective randomized trial.","volume":"8","author":"Margreiter","year":"2008","journal-title":"Am J Transplant"},{"key":"R16-12-20210129","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1046\/j.1600-6135.2003.00275.x","article-title":"Poor predictive value of serum creatinine for renal allograft loss.","volume":"3","author":"Kaplan","year":"2003","journal-title":"Am J Transplant"},{"key":"R17-12-20210129","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1523-1755.2002.00424.x","article-title":"Post-transplant renal function in the first year predicts long-term kidney transplant survival.","volume":"62","author":"Hariharan","year":"2002","journal-title":"Kidney Int"},{"key":"R18-12-20210129","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1681\/ASN.2009020171","article-title":"Measured GFR as a confirmatory test for estimated GFR.","volume":"20","author":"Stevens","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R19-12-20210129","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/TP.0b013e3181613e65","article-title":"Poor tolerance of sirolimus in a steroid avoidance regimen for renal transplantation.","volume":"85","author":"Smith","year":"2008","journal-title":"Transplantation"},{"key":"R20-12-20210129","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/01.tp.0000166921.14670.33","article-title":"Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation.","volume":"80","author":"Vathsala","year":"2005","journal-title":"Transplantation"},{"key":"R21-12-20210129","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/01.tp.0000263344.53000.a1","article-title":"Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation.","volume":"83","author":"Thomas","year":"2007","journal-title":"Transplantation"},{"key":"R22-12-20210129","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation.","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"R23-12-20210129","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy.","volume":"349","author":"Nankivell","year":"2003","journal-title":"N Engl J Med"},{"key":"R24-12-20210129","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/01.TP.0000071362.99021.D9","article-title":"Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (Campath-1H).","volume":"76","author":"Kirk","year":"2003","journal-title":"Transplantation"},{"key":"R25-12-20210129","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/01.tp.0000174341.49741.8f","article-title":"Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin.","volume":"80","author":"Kirk","year":"2005","journal-title":"Transplantation"},{"key":"R26-12-20210129","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1034\/j.1600-6143.2003.00120.x","article-title":"Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study.","volume":"3","author":"Knechtle","year":"2003","journal-title":"Am J Transplant"},{"key":"R27-12-20210129","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/TP.0b013e318257ad41","article-title":"Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis.","volume":"93","author":"Morgan","year":"2012","journal-title":"Transplantation"},{"key":"R28-12-20210129","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/infdis\/jis642","article-title":"Early BKV reactivation in donor kidney is a risk factor for development of BK polyomavirus associated nephropathy.","volume":"207","author":"Saundh","year":"2013","journal-title":"J Infect Dis"},{"key":"R29-12-20210129","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1600-6143.2007.01972.x","article-title":"Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab.","volume":"7","author":"Kirk","year":"2007","journal-title":"Am J Transplant"},{"key":"R30-12-20210129","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1432-2277.2009.00877.x","article-title":"Effect of conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium on maximum tolerated dose and gastrointestinal symptoms following kidney transplantation.","volume":"22","author":"Shehata","year":"2009","journal-title":"Transpl Int"},{"key":"R31-12-20210129","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence.","volume":"12","author":"Sellares","year":"2012","journal-title":"Am J Transplant"},{"key":"R32-12-20210129","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1600-6143.2010.03421.x","article-title":"Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy.","volume":"11","author":"Willicombe","year":"2011","journal-title":"Am J Transplant"},{"key":"R33-12-20210129","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1600-6143.2011.03891.x","article-title":"An analysis of lymphocyte phenotype after steroid avoidance with either alemtuzumab or basiliximab induction in renal transplantation.","volume":"12","author":"Cherukuri","year":"2012","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0b013e3182a64db9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:36:28Z","timestamp":1620977788000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201312270-00012"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2013,12,27]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3182a64db9","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12,27]]}}}